SHELBY WARREN: Open Payments
NPI 1598381097 · NORTHPORT, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,250 in 78 payments from 16 companies in 2025. Trend: 2023 $1,123 · 2024 $1,523 · 2025 $1,250
Food & beverage: $1,250
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $371 |
| Novartis Pharmaceuticals Corporation | 23 | $295 |
| Galderma Laboratories, L.P. | 10 | $145 |
| LEO Pharma Inc. | 3 | $69 |
| GENZYME CORPORATION | 2 | $50 |
| Lilly USA, LLC | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 2 | $39 |
| Amgen Inc. | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $33 |
Products named: COSENTYX, RINVOQ, SKYRIZI, NEMLUVIO, DUPIXENT, ADBRY, EBGLYSS, Otezla.
Industry payments across AL — which companies pay providers there.
